Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-03-11

Clinical Trial Update: Prevention of Contrast Renal Injury With Different Hydration Strategies [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing different hydration strategies to prevent contrast-induced nephropathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Kaiser Permanente | Conditions: Contrast Medium-induced Nephropathy | Phase 3 | Status: COMPLETED